Injectable Drug Delivery Market by Administration (Musculoskeletal, Skin), Type (Formulation, Device), Therapeutic (Cancer), Usage Pattern (Immunization), Patient Care Setting (Hospital, Home Care), Distribution Channel (Hospital) – 2024 to 2029

SKU: GMS-3020

Format: PDF

Overall Rating
4.5/5

OVERVIEW

The Injectable Drug Delivery Market is calculated to reach USD 162.3 billion by 2025, growing at a CAGR of 13.78% during the forecast period 2020-2025. The increasing prevalence of chronic diseases, rising aging population, increasing use of biologics is analyzed to drive the market growth. Moreover, the growing occurrence of needlestick injuries, and the benefits of injections is also propelling the growth of market.

Injectable drug delivery market by administration (musculoskeletal, skin), type (formulation, device), therapeutic (cancer), usage pattern (immunization), patient care setting (hospital, home care), distribution channel (hospital) - 2024 to 2029 1

Injectable drug delivery market by administration (musculoskeletal, skin), type (formulation, device), therapeutic (cancer), usage pattern (immunization), patient care setting (hospital, home care), distribution channel (hospital) - 2024 to 2029 2

Injectable drug delivery market by administration (musculoskeletal, skin), type (formulation, device), therapeutic (cancer), usage pattern (immunization), patient care setting (hospital, home care), distribution channel (hospital) - 2024 to 2029 3

Injectable drug delivery market by administration (musculoskeletal, skin), type (formulation, device), therapeutic (cancer), usage pattern (immunization), patient care setting (hospital, home care), distribution channel (hospital) - 2024 to 2029 4

Injectable drug delivery market by administration (musculoskeletal, skin), type (formulation, device), therapeutic (cancer), usage pattern (immunization), patient care setting (hospital, home care), distribution channel (hospital) - 2024 to 2029 5

Injectable drug delivery market by administration (musculoskeletal, skin), type (formulation, device), therapeutic (cancer), usage pattern (immunization), patient care setting (hospital, home care), distribution channel (hospital) - 2024 to 2029 6

Injectable drug delivery market by administration (musculoskeletal, skin), type (formulation, device), therapeutic (cancer), usage pattern (immunization), patient care setting (hospital, home care), distribution channel (hospital) - 2024 to 2029 7

Injectable drug delivery market by administration (musculoskeletal, skin), type (formulation, device), therapeutic (cancer), usage pattern (immunization), patient care setting (hospital, home care), distribution channel (hospital) - 2024 to 2029 8

TABLE OF CONTENT

1 Global Injectable Drug Delivery Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Injectable Drug Delivery Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Injectable Drug Delivery Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Injectable Drug Delivery Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Injectable Drug Delivery Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Injectable Drug Delivery Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Injectable Drug Delivery Market – By Type (Market Size – & million/billion)
8.1 Device
8.2 Formulations

9 Global Injectable Drug Delivery Market – By Packaging
9.1 Cartridges
9.2 Bottles
9.3 Vials
9.4 Ampules

10 Global Injectable Drug Delivery Market – By Therapeutic Application
10.1 Autoimmune Diseases
10.2 Orphan Diseases
10.3 Hormonal Disorders
10.4 Cancer
10.5 Others

11 Global Injectable Drug Delivery Market – By Application
11.1 Respiratory diseases
11.2 Diabetes
11.3 Hormones replacement
11.4 Neurology addiction
11.5 Cardiovascular diseases
11.6 Others

12 Global Injectable Drug Delivery Market – By Distribution Channel
12.1 Hospital
12.2 Retail Pharmacy Stores

13 Global Injectable Drug Delivery Market – By End-User
13.1.1 Hospitals
13.1.2 Clinics
13.1.3 Home Care
13.1.4 Others

14 Global Injectable Drug Delivery Market – By Geography (Market Size – & million/billion)
14.1 Introduction
14.2 North America
14.2.1 US
14.2.2 Canada
14.2.3 Mexico
14.3 Europe
14.3.1 U.K
14.3.2 Germany
14.3.3 Italy
14.3.4 France
14.3.5 Spain
14.3.6 Rest of Europe
14.4 Asia-Pacific
14.4.1 China
14.4.2 Japan
14.4.3 India
14.4.4 South Korea
14.4.5 Rest of APAC
14.5 Rest of the World
14.5.1 South America
14.5.2 Middle East
14.5.3 Africa

15 Global Injectable Drug Delivery Market – Entropy
15.1 New product launches
15.2 M&A’s, collaborations, JVs and partnerships

16 Global Injectable Drug Delivery Market Company Profile (Key Players)
16.1 Market Share, Company Revenue, Products, M&A, Developments
16.2 Baxter International, Inc.
16.3 Becton, Dickinson and Company
16.4 Pfizer, Inc.
16.5 Genentech Inc.
16.6 Polymer Factory
16.7 Schott AG
16.8 Teva Pharmaceutical Industries Ltd.
16.9 Sandoz (A Division of Novartis AG)
16.10 Terumo Corporation
16.11 Presage Bioscience
16.12 Company 11 & more

17 Global Injectable Drug Delivery Market – Appendix
17.1 Sources
17.2 Abbreviations

Share

Get A Free Sample

Take a look at this complimentary sample which comprises of a variety of market data points such as trend analyses, market estimates, and forecasts. You can explore and evaluate it on your own.

Send me Free Sample

Or View Our License Options:

$3,850.00$5,850.00

Why

Industry Coverage: Global Market Studies has a broad range of industry coverage, spanning various sectors such as healthcare, technology, retail, automotive, and many others. This means that clients can rely on us to provide valuable insights into their respective industries, helping them make informed business decisions.

Our team of experts has years of experience in the market research industry, and they have honed their skills in data analysis, market forecasting, and trend analysis. They are also adept at using advanced research tools and techniques to gather and analyze data, providing clients with accurate and reliable insights.

We understand that each client has unique research needs, and we tailor our research solutions to meet their specific requirements. We work closely with our clients to understand their objectives and provide customized research solutions that address their business challenges.

We are committed to innovation and are constantly exploring new research methods and techniques to provide our clients with cutting-edge insights. This enables us to stay ahead of the curve and deliver the best possible research outcomes.

At Global Market Studies, our clients are at the center of everything we do. We pride ourselves on providing excellent customer service and support, and we are always available to address our clients’ concerns and questions.

83422+ Reports Delivered

Accurate market data is crucial to a successful business strategy. With an 85% + accuracy in all reports, makes us one of the best and most accurate firms in the world.

Need Customized Report ?Call Now

OVERVIEW

The Injectable Drug Delivery Market is calculated to reach USD 162.3 billion by 2025, growing at a CAGR of 13.78% during the forecast period 2020-2025. The increasing prevalence of chronic diseases, rising aging population, increasing use of biologics is analyzed to drive the market growth. Moreover, the growing occurrence of needlestick injuries, and the benefits of injections is also propelling the growth of market.

Injectable drug delivery market by administration (musculoskeletal, skin), type (formulation, device), therapeutic (cancer), usage pattern (immunization), patient care setting (hospital, home care), distribution channel (hospital) - 2024 to 2029 9

Injectable drug delivery market by administration (musculoskeletal, skin), type (formulation, device), therapeutic (cancer), usage pattern (immunization), patient care setting (hospital, home care), distribution channel (hospital) - 2024 to 2029 10

Injectable drug delivery market by administration (musculoskeletal, skin), type (formulation, device), therapeutic (cancer), usage pattern (immunization), patient care setting (hospital, home care), distribution channel (hospital) - 2024 to 2029 11

Injectable drug delivery market by administration (musculoskeletal, skin), type (formulation, device), therapeutic (cancer), usage pattern (immunization), patient care setting (hospital, home care), distribution channel (hospital) - 2024 to 2029 12

Injectable drug delivery market by administration (musculoskeletal, skin), type (formulation, device), therapeutic (cancer), usage pattern (immunization), patient care setting (hospital, home care), distribution channel (hospital) - 2024 to 2029 13

Injectable drug delivery market by administration (musculoskeletal, skin), type (formulation, device), therapeutic (cancer), usage pattern (immunization), patient care setting (hospital, home care), distribution channel (hospital) - 2024 to 2029 14

Injectable drug delivery market by administration (musculoskeletal, skin), type (formulation, device), therapeutic (cancer), usage pattern (immunization), patient care setting (hospital, home care), distribution channel (hospital) - 2024 to 2029 15

Injectable drug delivery market by administration (musculoskeletal, skin), type (formulation, device), therapeutic (cancer), usage pattern (immunization), patient care setting (hospital, home care), distribution channel (hospital) - 2024 to 2029 16

TABLE OF CONTENT

1 Global Injectable Drug Delivery Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Injectable Drug Delivery Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Injectable Drug Delivery Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Injectable Drug Delivery Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Injectable Drug Delivery Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Injectable Drug Delivery Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Injectable Drug Delivery Market – By Type (Market Size – & million/billion)
8.1 Device
8.2 Formulations

9 Global Injectable Drug Delivery Market – By Packaging
9.1 Cartridges
9.2 Bottles
9.3 Vials
9.4 Ampules

10 Global Injectable Drug Delivery Market – By Therapeutic Application
10.1 Autoimmune Diseases
10.2 Orphan Diseases
10.3 Hormonal Disorders
10.4 Cancer
10.5 Others

11 Global Injectable Drug Delivery Market – By Application
11.1 Respiratory diseases
11.2 Diabetes
11.3 Hormones replacement
11.4 Neurology addiction
11.5 Cardiovascular diseases
11.6 Others

12 Global Injectable Drug Delivery Market – By Distribution Channel
12.1 Hospital
12.2 Retail Pharmacy Stores

13 Global Injectable Drug Delivery Market – By End-User
13.1.1 Hospitals
13.1.2 Clinics
13.1.3 Home Care
13.1.4 Others

14 Global Injectable Drug Delivery Market – By Geography (Market Size – & million/billion)
14.1 Introduction
14.2 North America
14.2.1 US
14.2.2 Canada
14.2.3 Mexico
14.3 Europe
14.3.1 U.K
14.3.2 Germany
14.3.3 Italy
14.3.4 France
14.3.5 Spain
14.3.6 Rest of Europe
14.4 Asia-Pacific
14.4.1 China
14.4.2 Japan
14.4.3 India
14.4.4 South Korea
14.4.5 Rest of APAC
14.5 Rest of the World
14.5.1 South America
14.5.2 Middle East
14.5.3 Africa

15 Global Injectable Drug Delivery Market – Entropy
15.1 New product launches
15.2 M&A’s, collaborations, JVs and partnerships

16 Global Injectable Drug Delivery Market Company Profile (Key Players)
16.1 Market Share, Company Revenue, Products, M&A, Developments
16.2 Baxter International, Inc.
16.3 Becton, Dickinson and Company
16.4 Pfizer, Inc.
16.5 Genentech Inc.
16.6 Polymer Factory
16.7 Schott AG
16.8 Teva Pharmaceutical Industries Ltd.
16.9 Sandoz (A Division of Novartis AG)
16.10 Terumo Corporation
16.11 Presage Bioscience
16.12 Company 11 & more

17 Global Injectable Drug Delivery Market – Appendix
17.1 Sources
17.2 Abbreviations

Download our eBook: Market Mastery

Unleashing revenue potential through strategic market research involves identifying untapped market opportunities, understanding consumer needs and preferences, and developing targeted strategies to capitalize on them. By leveraging data-driven insights, businesses can optimize product offerings, pricing strategies, and marketing efforts to drive revenue growth and stay ahead of competitors.

Related Research Reports